68Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy-Reference-Cited by-同舟云学术

68Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy

Published:2019-04 Issue:4 Volume:26 Page:450-460
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Hamed Maged Abdel Galil,Basha Mohammad Abd Alkhalik^ORCID,Ahmed Hussien,Obaya Ahmed Ali,Afifi Amira Hamed Mohamed,Abdelbary Eman H.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference37 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—Update 2013;Heidenreich;Eur Urol,2014

3. Cancer statistics 2014;Siegel;CA-Cancer J Clin,2014

4. Role of 18F-choline PET/CT in evaluation of patients with prostate carcinoma;Hodolic;Radiol Oncol,2011

5. Radiotherapy in palliative treatment of painful bone metastases;Horvat;Radiol Oncol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies;Academic Radiology;2023-09

2. Application of 68Ga-PSMA-11 PET/CT in the Diagnosis of Prostate Cancer Clinical Relapse;Current Radiopharmaceuticals;2022-09

3. Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis;European Radiology;2022-04-29

4. 68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis;International braz j urol;2021-08

5. The value of intravenous contrast medium in PSMA PET/CT imaging in patients with biochemical recurrence of prostate cancer;Nuclear Medicine Communications;2021-06-14